-+ 0.00%
-+ 0.00%
-+ 0.00%

MESOBLAST - REXLEMESTROCEL-L RECEIVES ORPHAN DRUG AND RMAT DESIGNATIONS

Reuters·06/30/2026 23:56:53

Please log in to view news